Article

LINC00461 Regulates the Recurrence of Large B Cell Lymphoma through the miR-411-5p/BNIP3…

Evidence-Based Complementary and Alternative Medicine · 2022 · Shu-wen Sun, author Yan Chen, author Hui-juan Liao, author Wei Zhang, author Wen-ming Xu, author Guo-qian He, author Xi Wei, Academic Editor

Key facts

Title LINC00461 Regulates the Recurrence of Large B Cell Lymphoma through the miR-411-5p/BNIP3 Pathway
First author Shu-wen Sun, author Yan Chen, author Hui-juan Liao, author Wei Zhang, author Wen-ming Xu, author Guo-qian He, author Xi Wei, Academic Editor
Journal Evidence-Based Complementary and Alternative Medicine
Published Mar 26, 2022
DOI 10.1155/2022/9100056
Devices mentioned 202002, K040782
Product codes mentioned JAK

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature